vs

Side-by-side financial comparison of MARCUS CORP (MCS) and Sabra Health Care REIT, Inc. (SBRA). Click either name above to swap in a different company.

Sabra Health Care REIT, Inc. is the larger business by last-quarter revenue ($221.8M vs $193.5M, roughly 1.1× MARCUS CORP). On growth, Sabra Health Care REIT, Inc. posted the faster year-over-year revenue change (20.8% vs 2.8%). Over the past eight quarters, MARCUS CORP's revenue compounded faster (18.2% CAGR vs 12.2%).

Marcus & Millichap, Inc. is an American company that provides real estate brokerage, mortgage brokerage, research, and advisory services in the U.S. and Canada in the field of commercial property. It popularized the practice of listing properties exclusively with one brokerage firm. The company has over 1,800 employees in more than 80 offices across the U.S. and Canada.

Sabra Health Care REIT, Inc. is a specialized real estate investment trust that owns, manages, and invests in a diverse portfolio of healthcare real estate assets. Its core holdings include senior housing facilities, skilled nursing centers, specialty hospital properties, and medical office buildings across the United States, serving key segments of the growing senior care and healthcare delivery markets.

MCS vs SBRA — Head-to-Head

Bigger by revenue
SBRA
SBRA
1.1× larger
SBRA
$221.8M
$193.5M
MCS
Growing faster (revenue YoY)
SBRA
SBRA
+18.1% gap
SBRA
20.8%
2.8%
MCS
Faster 2-yr revenue CAGR
MCS
MCS
Annualised
MCS
18.2%
12.2%
SBRA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MCS
MCS
SBRA
SBRA
Revenue
$193.5M
$221.8M
Net Profit
$40.8M
Gross Margin
Operating Margin
0.9%
Net Margin
18.4%
Revenue YoY
2.8%
20.8%
Net Profit YoY
1.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCS
MCS
SBRA
SBRA
Q1 26
$221.8M
Q4 25
$193.5M
$211.9M
Q3 25
$210.2M
$190.0M
Q2 25
$206.0M
$189.2M
Q1 25
$148.8M
$183.5M
Q4 24
$188.3M
$182.3M
Q3 24
$232.7M
$178.0M
Q2 24
$176.0M
$176.1M
Net Profit
MCS
MCS
SBRA
SBRA
Q1 26
$40.8M
Q4 25
$27.2M
Q3 25
$16.2M
$22.5M
Q2 25
$7.3M
$65.5M
Q1 25
$-16.8M
$40.3M
Q4 24
$986.0K
$46.7M
Q3 24
$23.3M
$29.8M
Q2 24
$-20.2M
$24.0M
Operating Margin
MCS
MCS
SBRA
SBRA
Q1 26
Q4 25
0.9%
12.3%
Q3 25
10.8%
11.4%
Q2 25
6.3%
34.5%
Q1 25
-13.7%
22.1%
Q4 24
-1.2%
25.9%
Q3 24
14.1%
16.5%
Q2 24
1.3%
13.8%
Net Margin
MCS
MCS
SBRA
SBRA
Q1 26
18.4%
Q4 25
12.8%
Q3 25
7.7%
11.9%
Q2 25
3.6%
34.7%
Q1 25
-11.3%
22.0%
Q4 24
0.5%
25.6%
Q3 24
10.0%
16.7%
Q2 24
-11.5%
13.6%
EPS (diluted)
MCS
MCS
SBRA
SBRA
Q1 26
Q4 25
$0.11
Q3 25
$0.09
Q2 25
$0.27
Q1 25
$0.17
Q4 24
$0.20
Q3 24
$0.13
Q2 24
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCS
MCS
SBRA
SBRA
Cash + ST InvestmentsLiquidity on hand
$23.4M
$116.5M
Total DebtLower is stronger
$159.0M
Stockholders' EquityBook value
$457.4M
$2.8B
Total Assets
$1.0B
$5.6B
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCS
MCS
SBRA
SBRA
Q1 26
$116.5M
Q4 25
$23.4M
$71.5M
Q3 25
$7.4M
$200.6M
Q2 25
$14.9M
$95.2M
Q1 25
$11.9M
$22.7M
Q4 24
$40.8M
$60.5M
Q3 24
$28.4M
$63.0M
Q2 24
$32.8M
$36.4M
Total Debt
MCS
MCS
SBRA
SBRA
Q1 26
Q4 25
$159.0M
$2.5B
Q3 25
$162.0M
$2.6B
Q2 25
$179.9M
$2.5B
Q1 25
$198.9M
$2.4B
Q4 24
$159.1M
$2.4B
Q3 24
$173.1M
$2.5B
Q2 24
$175.7M
$2.4B
Stockholders' Equity
MCS
MCS
SBRA
SBRA
Q1 26
$2.8B
Q4 25
$457.4M
$2.8B
Q3 25
$454.3M
$2.8B
Q2 25
$448.4M
$2.7B
Q1 25
$441.8M
$2.7B
Q4 24
$464.9M
$2.7B
Q3 24
$462.3M
$2.7B
Q2 24
$449.4M
$2.8B
Total Assets
MCS
MCS
SBRA
SBRA
Q1 26
$5.6B
Q4 25
$1.0B
$5.5B
Q3 25
$1.0B
$5.6B
Q2 25
$1.0B
$5.3B
Q1 25
$1.0B
$5.2B
Q4 24
$1.0B
$5.3B
Q3 24
$1.0B
$5.4B
Q2 24
$1.1B
$5.4B
Debt / Equity
MCS
MCS
SBRA
SBRA
Q1 26
Q4 25
0.35×
0.90×
Q3 25
0.36×
0.92×
Q2 25
0.40×
0.91×
Q1 25
0.45×
0.89×
Q4 24
0.34×
0.88×
Q3 24
0.37×
0.90×
Q2 24
0.39×
0.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCS
MCS
SBRA
SBRA
Operating Cash FlowLast quarter
$48.8M
$98.4M
Free Cash FlowOCF − Capex
$26.4M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
11.6%
Cash ConversionOCF / Net Profit
2.41×
TTM Free Cash FlowTrailing 4 quarters
$989.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCS
MCS
SBRA
SBRA
Q1 26
$98.4M
Q4 25
$48.8M
$348.6M
Q3 25
$39.1M
$100.0M
Q2 25
$31.6M
$81.0M
Q1 25
$-35.3M
$80.3M
Q4 24
$52.6M
$310.5M
Q3 24
$30.5M
$97.7M
Q2 24
$36.0M
$80.1M
Free Cash Flow
MCS
MCS
SBRA
SBRA
Q1 26
Q4 25
$26.4M
Q3 25
$18.2M
Q2 25
$14.7M
Q1 25
$-58.3M
Q4 24
$27.1M
Q3 24
$12.0M
Q2 24
$16.1M
FCF Margin
MCS
MCS
SBRA
SBRA
Q1 26
Q4 25
13.6%
Q3 25
8.7%
Q2 25
7.1%
Q1 25
-39.2%
Q4 24
14.4%
Q3 24
5.2%
Q2 24
9.2%
Capex Intensity
MCS
MCS
SBRA
SBRA
Q1 26
Q4 25
11.6%
Q3 25
9.9%
Q2 25
8.2%
Q1 25
15.5%
Q4 24
13.5%
Q3 24
7.9%
Q2 24
11.3%
Cash Conversion
MCS
MCS
SBRA
SBRA
Q1 26
2.41×
Q4 25
12.80×
Q3 25
2.41×
4.44×
Q2 25
4.32×
1.24×
Q1 25
1.99×
Q4 24
53.31×
6.65×
Q3 24
1.31×
3.28×
Q2 24
3.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MCS
MCS

Theatres$123.1M64%
Concessions$51.0M26%
Food And Beverage$21.2M11%

SBRA
SBRA

Resident fees and services$116.7M53%
Rental and related revenues (1)$95.0M43%
Other$10.0M5%

Related Comparisons